Robert Newman

Robert Newman has a strong background in pharmaceutical sales and account representation, with experience in launching various therapeutic products across different companies. Robert currently holds the position of Immunology Account Representative at Touchpoint Solutions and has worked in various roles such as VP of Sales at Trak-1, Cystic Fibrosis Therapeutic Specialist at Vertex Pharmaceuticals, and District Manager at Eurand Pharmaceuticals. Newman's expertise includes launching products like Kalydeco, Zenpep, Creon Marinol, Rowasa, and Aquatab (now known as Mucinex). Currently, Robert serves as an Executive BioSimilar Account Specialist and Senior Biosimilar Account Specialist at Amplity Health, specializing in Oncology, Rheumatology, and Gastroenterology.